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ABSTRACT 
In this paper, we seek to understand the causes of chronic anxiety in order to learn how to 
overcome this disorder. Previous research has found that decreases in anxiety are associated with 
decreases in amygdala activity and increases in consumption of the fatty acid DHA, while 
increases in anxiety are associated with having higher levels of the inflammatory protein 
interleukin-6. In our correlational study, we tested the strength of these relationships by 
examining naturalistic daily changes in their variables longitudinally over a two-week period. 
We measured amygdala activity by measuring the difference in heart rate before and after 
watching a scary video, DHA levels by calculating the amount of DHA consumed each day, 
levels of interleukin-6 by daily body temperature daily, and anxiety levels by ratings on a scale 
of 0-10. Data pooled across participants in our correlation study showed significant correlations 




1.1 Research Problem 
 
Understanding the biological mechanism 
of chronic anxiety can help identify why 
people experience chronic anxiety and ways 
to overcome it. People who have anxiety 
over long periods of time may experience 
negative related health problems and 
learning about what causes chronic anxiety 
and stress can help prevent such problems 
and help people live a better and more 
positive life. Additionally, if people 
understand why they experience chronic 
anxiety then they can implement ways to 
overcome or mitigate it. Anxiety is your 
body's natural response to stress. It orients 
us to danger and prepares our bodies to 
either challenge it or escape it. Learning 
about why we experience chronic anxiety 
can benefit people in numerous ways as 
chronic anxiety can leave a person feeling 
on edge all the time. If we learn ways to 
overcome this condition, many who suffer 
from this condition could get relief and live 
a more positive lifestyle.  
 
1.2 Literature Review 
 
One factor previously found to decrease 
chronic anxiety is a decrease in amygdala 
glutamate activity. According to Ullmann et 
al. (2019), levels of anxiety were decreased 
in rats that are engaging in active offensive 
response behavioral strategies to chronic 
predator scent stress and show lower plasma 
cortisol levels vs. rats engaging in passive 
defensive response behavioral strategies to 
chronic predator scent stress. Rats that are 




engaging in active offensive response also 
have higher lactate and lower glutamate 
levels in amygdala. The researchers used 28 
rats and divided them into two phenotypes 
based on their behaviour in anxiety related 
situations. The first phenotype was the 
active offensive response group which was 
the control group of the experiment and the 
second phenotype was the passive defensive 
response group. The cages with control 
groups, which were the active response rats, 
got clear sawdust without cat urine 
contamination in their cages while defensive 
response rats got the cages with the cat 
urination contaminated sawdust (20 rats 
were submitted to stress exposure; 8 control 
rats were exposed to a neutral scent). This 
study demonstrated decreased excitatory 
glutamate activity in the amygdala of active 
offensive response rats vs. in passive 
defensive response rats after chronic 
predator stress, suggesting a possible 
endogenous calming psychophysiological 
mechanism in the active offensive response 
phenotype.   
The type and quantity of fatty acids a 
person consumes may be directly linked to 
the level of stress and anxiety they 
experience.  Hashemi et al. (2020) found 
that higher consumption of docosahexaenoic 
acid (DHA) is linked to a protective effect 
on stress and anxiety levels. They used a 
case control study to measure the effects of 
the fatty acid profile in erythrocytes (red 
blood cell), which is a long-term marker for 
dietary fat consumption. The researchers 
used 45 students in each case and control 
group and gave them all a questionnaire that 
measured stress/anxiety levels, dietary 
intake, and general characteristics that 
include weight, age and physical activity; 
Additionally, they were given a blood test to 
measure the fatty acid content in their red 
blood cells. Hashemi et al. (2020) found that 
DHA levels were lower in the anxiety group. 
Thus, having higher DHA may reduce the 
risk of anxiety.  
Higher levels of inflammatory proteins 
are found in people that experience higher 
levels of anxiety. According to Moriarity et 
al. (2018), interleukin-6 (proinflammation 
marker) levels were higher in the subjects 
that experienced anxiety. The researchers 
recruited 640 adolescents originally, but 
blood samples were only taken after 4 years 
into the study with 140 of the subjects 
participating in this part of the research. The 
researchers took blood samples from the 140 
participants 2 times with an average time of 
about a year in between to measure 
inflammatory proteins. Moreover, they had 
the subjects self- report their anxiety at the 
second visit. The researchers found that 
anxiety was correlated with higher amounts 
of inflammatory proteins. Thus, 




• Hypothesis #1: If amygdala activity 
increases then anxiety will increase. 
• Hypothesis #2: If consumption of 
DHA increases then anxiety will decrease 
• Hypothesis #3: If levels of 







The two authors of this paper served as 
the participants in its studies. The 
participants ranged in age from 20 to 42 
years old, with an average age of 31 years, 
and included two women. The participants 
were all undergraduate students at Camosun 
College who completed the current studies 
as an assignment for Psyc 215 (“Biological 
Psychology”) and were grouped together 




due to their mutual interest in the causes of 
anxiety and stress. 
 
2.2 Materials and Procedure 
 
We performed a correlational study to 
test concurrently all of our hypotheses by 
examining naturalistic daily changes in their 
variables longitudinally. Each participant 
kept a study journal with them at all times 
over this study’s two-week period in order to 
record self-observations of the following 4 
variables: (1) amygdala activity, (2) Intake 
of DHA, (3) interleukin- 6 levels and (4) 
anxiety levels 
To measure amygdala activity, each 
participant recorded their heart rate by 
checking their pulse twice a day: once 
before and once after watching 4:38 minutes 
of a scary video clip from YouTube (see 
Appendix for the link). The difference in 
heart rate between these two time points was 
then calculated. 
To measure DHA levels, each participant 
calculated how much DHA they consumed 
at the end of each day by reading food labels 
and looking up DHA levels in foods without 
labels from the list found in the Appendix.  
To measure the interleuken-6 levels, each 
participant took their temperature 3 times a 
day (morning, noon and night) and recorded 
their average temperature for the day.  
To measure the anxiety levels, each 
participant rated on a 0 to 10 scale how 
much anxiety they felt throughout each 
following day of this study. Participants 
recorded in a study journal how much 
anxiety they felt three times a day (morning, 
noon, and night). The following response 
were used on the anxiety scale: 0= not 
feeling anxious at all to 10=feeling 
extremely anxious. From these records, the 
average level of anxiety of each participant 
for each day was calculated.  
To assess the strength and statistical 
significance of associations between 
variables predicted by our 3 hypotheses, we 
performed Pearson product moment 
correlations of their predictor variables 
(amygdala, DHA, interleukin-6) with their 
outcome variable (anxiety). For testing 
Hypotheses #1, we correlated the heart rate 
of each participant with that participant’s 
average anxiety score for each day.  For 
testing Hypothesis #2, we correlated the 
intake of DHA of each participant with that 
participant’s average anxiety score for each 
day. For testing Hypothesis #3, we 
correlated body temperature with the 
participant’s anxiety score for each day. We 
performed all of the above correlations 
separately for each participant as well as 
using data pooled across all of the 
participants. For the correlations using 
pooled data, in addition to using the raw 
data, we also performed correlations after 
we had first transformed the data from each 
participant into z-scores in order to 
standardize differences in averages and 
variability seen between the participants in 
their data and thus make them more 
comparable. A correlation coefficient was 
considered statistically significant if the 
probability of its random occurrence (p) was 
< .05 (i.e., less than 5% of the time expected 




As shown in Table 1, amygdala activity 
and DHA were significantly correlated with 
anxiety levels. Although not being 
statistically correlated for participant #2 (r 
=0.43, p =0.125), amygdala activity was 
significantly correlated for participant #1 (r 
=0.64, p =0.012) and using the pooled 
standardized data (r =0.53, p =0.0029). 
DHA and anxiety levels were only 
significantly correlated using the pooled 




standardized data (r =-0.40, p =0.035). In 
contrast, no statistically significant 
correlation was found between interleuken-6 
and anxiety levels in any single participant’s 
data (all r ≥ -0.26, all p ≥ 0.38) nor using the 
pooled standardized data (r = -0.08, p = 
0.68). Based on a comparison of the 
correlation coefficients using the pooled 
standardized data, amygdala activity levels 





4.1 Summary of Results 
 
Based on previous research, we 
hypothesized that increases in three 
variables would be followed by less severe 
anxiety experienced after checking our heart 
rate: amygdala activity (Hypothesis #1), 
intake of DHA (Hypothesis #2), and 
interleukin-6 levels (Hypothesis #3). Data 
pooled across participants in our 
correlational study supported the predicted 
relationship of anxiety with amygdala 
activity and intake of DHA (Hypotheses 
#1&2) but not with interleukin-6 levels 
(Hypothesis #3).  
 
4.2 Relation of Results to Past Research 
 
The ability of our correlational study to 
predict anxiety severity based on amygdala 
glutamate activity is in line with previous 
research. Ullmann et al. (2019) found that 
decreases in amygdala glutamate activity 
reported by active offensive response rats 
was associated with a decrease in anxiety 
levels. While Ullmann et al. (2019) 
experimented on 28 male Sprague-Dawley 
rats, assessing their amygdala activity and 
anxiety levels, we longitudinally assessed 
these variables in students. The similarity of 
both our conclusions despite using different 
research designs suggests a generalized 
relationship exists between decreased 
amygdala glutamate activity and decrease 
anxiety levels. 
Our correlational study confirmed the 
relationship between DHA intake and 
anxiety levels, reported by previous 
research. Hashemi et al. (2020), found that 
higher levels of consumption of DHA had a 
protective effect on anxiety levels. The 
methodology of our correlational study 
differed from that of Hashemi et al. (2020), 
in that our correlational study measured 
DHA intake by reading labels and 
estimating how much DHA we had 
consumed throughout the day, while Hashmi 
et al. (2020) measured the fatty acid profile 
of the participants red blood cells. Despite 
these differences in methodology, the 
previous results were replicated. 
Our correlational study failed to confirm 
the relationship between interleukin-6 levels 
and anxiety level as reported by previous 
research. Moriarty et al. (2018) found that 
higher levels of interleukin-6 were found in 
subjects that experienced a variety of mental 
health challenges, including anxiety. The 
methodology of our correlational study 
differed from that of Moriarty et al. (2018) 
in that we measured interleukin-6 levels by 
taking our temperature daily while Molarity 
et al. (2018) measured interleukin-6 levels 
by taking blood samples. This could be the 
reason for the difference in results between 





Hashemi, S., Amani, R., Cheraghian, B., & 
Neamatpour, S. (2020). Stress and 
anxiety levels are associated with 
erythrocyte fatty acids content in young 
women. Iranian Journal of Psychiatry, 
15(1), 47–54.  




Moriarity, D. P., McArthur, B. A., Ellman, 
L. M., Coe, C. L., Abramson, L. Y., & 
Alloy, L. B. (2018). Immunocognitive 
model of depression secondary to anxiety 
in adolescents. Journal of Youth and 




Ullmann, E., Perry, S. W., Licinio, J., Wong, 
M. L., Dremencov, E., Zavjalov, E. L., ... 
& Tseilikman, V. (2019). From allostatic 
load to allostatic state—an endogenous 
sympathetic strategy to deal with chronic 
anxiety and stress?. Frontiers in 
Behavioral Neuroscience, 13, 47. 
doi:10.3389/fnbeh.2019.00047 
  
















Amygdala activity & 
Anxiety Scale 
0.64(14) 0.43(14)  0.56(28)* 0.53(28)* 
Intake of DHA &  
Anxiety Scale 
-0.43(14) -0.37(14)  -0.32(28) -0.40(28)* 
Interleuken-6 levels & 
Anxiety Scale 
0.09(14) -0.26(14)  -0.03(28) -0.08(28) 
* p < .05. 
 
Figure 1 
Scatterplot of Amygdala Activity and Anxiety Scale using pooled raw data across participants. 
 
Marker color indicates which participant data is from: red = participant #1 and orange = 





































Amygdala activity (difference in heart beat before/after video) (Beats per 
min.)
Pooled Raw Data





Scatterplot of intake of DHA and Anxiety level using pooled raw data across participants. 
  
Marker color indicates which participant data is from: red = participant #1 and orange = 
































Intake of DHA (milligrams)
Pooled Raw Data





Scatterplot of Interleuken-6 levels and Anxiety Level using pooled raw data across participants. 
 
 Marker color indicates which participant data is from: red = participant #1 and orange = 



































Interleuken-6 levels (Avreage body temature in celcius)
Pooled Raw Data





Table for measuring DHA levels in food 
Table 2: Selected Food Sources of ALA, EPA, and DHA [29] 
Food Grams per serving 
 
ALA DHA EPA 
Flaxseed oil, 1 tbsp 7.26 
  
Chia seeds, 1 ounce 5.06 
  
English walnuts, 1 ounce 2.57 
  
Flaxseed, whole, 1 tbsp 2.35 
  
Salmon, Atlantic, farmed cooked, 3 ounces 
 
1.24 0.59 
Salmon, Atlantic, wild, cooked, 3 ounces 
 
1.22 0.35 
Herring, Atlantic, cooked, 3 ounces* 
 
0.94 0.77 
Canola oil, 1 tbsp 1.28 
  
Sardines, canned in tomato sauce, drained, 3 ounces* 
 
0.74 0.45 
Mackerel, Atlantic, cooked, 3 ounces* 
 
0.59 0.43 
Salmon, pink, canned, drained, 3 ounces* 0.04 0.63 0.28 
Soybean oil, 1 tbsp 0.92 
  
Trout, rainbow, wild, cooked, 3 ounces 
 
0.44 0.40 
Black walnuts, 1 ounce 0.76 
  
Mayonnaise, 1 tbsp 0.74 
  
Oysters, eastern, wild, cooked, 3 ounces 0.14 0.23 0.30 
Sea bass, cooked, 3 ounces* 
 
0.47 0.18 
Edamame, frozen, prepared, ½ cup 0.28 
  
Shrimp, cooked, 3 ounces* 
 
0.12 0.12 
Refried beans, canned, vegetarian, ½ cup 0.21 
  
Lobster, cooked, 3 ounces* 0.04 0.07 0.10 
Tuna, light, canned in water, drained, 3 ounces* 
 
0.17 0.02 
Tilapia, cooked, 3 ounces* 0.04 0.11 
 
Scallops, cooked, 3 ounces* 
 
0.09 0.06 
Cod, Pacific, cooked, 3 ounces* 
 
0.10 0.04 




Tuna, yellowfin, cooked 3 ounces* 
 
0.09 0.01 
Kidney beans, canned ½ cup 0.10 
  
Baked beans, canned, vegetarian, ½ cup 0.07 
  
Ground beef, 85% lean, cooked, 3 ounces** 0.04 
  
Bread, whole wheat, 1 slice 0.04 
  




Chicken, breast, roasted, 3 ounces 
 
0.02 0.01 




Found on website  https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ 
Scary video https://www.youtube.com/watch?v=uZpMmP5EUEI 
